Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kairos Pharma, Ltd. (KAPA) Debt to Capital Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-2.60M |
|
-- |
|
-- |
|
$2.34M |
|
$-2.34M |
|
$-0.26M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.60M |
|
$-2.34M |
|
$-2.03M |
|
11.36M |
|
11.36M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$4.17M |
|
-- |
|
$1.60M |
|
$5.77M |
|
$0.99M |
|
-- |
|
-- |
|
$0.99M |
|
$4.78M |
|
$4.55M |
|
$4.78M |
|
13.74M |
|
| Cash Flow Statement Financials | |
$-3.96M |
|
-- |
|
$5.13M |
|
$0.09M |
|
$1.27M |
|
$1.18M |
|
$0.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.20 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.50% |
|
-57.16% |
|
-45.13% |
|
-54.50% |
|
$0.35 |
|
$-0.35 |
|
$-0.35 |
|